Marieke Voet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marieke Voet has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Elisabeth A. M. Cornelissen
Department of Pediatric Nephrology, Radboud University Medical Center, Amalia children’s Hospital, Nijmegen, The Netherlands
4 shared publications Joris Lemson
Department of Pediatric Intensive Care Amalia Children's Hospital, Radboud University Medical Center Nijmegen The Netherlands
4 shared publicationsIgnacio Malagon
Department of Anaesthesiology, Pain and Palliative Care, Radboud University Medical Center, GA Nijmegen, the Netherlands
2 shared publications- Ignacio Malagon
Department of Anesthesiology, Pain and Palliative Medicine Radboud university medical center Nijmegen The Netherlands
2 shared publications Yvonne Engels
Affiliation Department of Anaesthesiology, Pain and Palliative Medicine, Radboudumc, Nijmegen, The Netherlands
2 shared publicationsAlex Zarbock
Department Anesthesiology, Critical Care and Pain Medicine University Hospital Münster Münster Germany
1 shared publication
Latest Publications
- Open Access
- 2 June 2026
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (11) , 3987-3994
Cardiac adaptation in pediatric kidney transplant recipients with large donor–recipient size discrepancy: a speckle-tracking echocardiography study
Background: Pediatric living donor kidney transplantation (KT) with large donor-recipient size mismatch induces a large hemodynamic burden on the child recipient. Although successful KT is known to be beneficial for cardiac function and remodeling, its effects in small recipients with adult donors have not been evaluated. We aimed to describe left ventricular (LV) function and geometry using conventional and speckle-tracking echocardiography in this population. Methods: A prospective longitudinal study was performed. Living donor KT recipients with large donor-recipient size mismatch underwent conventional and speckle-tracking echocardiography prior to KT, shortly after KT and at 6 and 12 months post-transplantation. LV global longitudinal strain (GLS), LV ejection fraction, cardiac index, LV mass index (LVMi) and LV dimensions were obtained. Results: Ten patients were included with a median [IQR] age of 5.9 years [4.4–8.5]. The median donor–recipient body surface area ratio was 2.36. Prior to transplantation, LV systolic dysfunction was found in 80% of the patients (GLS −18.9% [−19.7–−18.7]). Significant improvement was found after 12 months (change in GLS −1.3% [−1.8–−0.9], p = 0.004). A significant reduction in LVMi was found at 6 months and 12 months of −8.9 g/m 2.7 [−15.6–−5.4], p = 0.01 and −14.3 g/m 2.7 [−15.3–−12.9], p = 0.004, respectively. No significant changes in cardiac index were found at 6 and 12 months. Conclusions: Despite the increased hemodynamic demands after pediatric KT with large donor-recipient size mismatch, improved LV function and reduced left ventricular mass were found within 1 year after transplantation. These results suggest reversed cardiac remodeling.
- 2 June 2026
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (11) , 3987-3994
Open AccessCardiac adaptation in pediatric kidney transplant recipients with large donor–recipient size discrepancy: a speckle-tracking echocardiography study
Background: Pediatric living donor kidney transplantation (KT) with large donor-recipient size mismatch induces a large hemodynamic burden on the child recipient. Although successful KT is known to be beneficial for cardiac function and remodeling, its effects in small recipients with adult donors have not been evaluated. We aimed to describe left ventricular (LV) function and geometry using conventional and speckle-tracking echocardiography in this population. Methods: A prospective longitudinal study was performed. Living donor KT recipients with large donor-recipient size mismatch underwent conventional and speckle-tracking echocardiography prior to KT, shortly after KT and at 6 and 12 months post-transplantation. LV global longitudinal strain (GLS), LV ejection fraction, cardiac index, LV mass index (LVMi) and LV dimensions were obtained. Results: Ten patients were included with a median [IQR] age of 5.9 years [4.4–8.5]. The median donor–recipient body surface area ratio was 2.36. Prior to transplantation, LV systolic dysfunction was found in 80% of the patients (GLS −18.9% [−19.7–−18.7]). Significant improvement was found after 12 months (change in GLS −1.3% [−1.8–−0.9], p = 0.004). A significant reduction in LVMi was found at 6 months and 12 months of −8.9 g/m 2.7 [−15.6–−5.4], p = 0.01 and −14.3 g/m 2.7 [−15.3–−12.9], p = 0.004, respectively. No significant changes in cardiac index were found at 6 and 12 months. Conclusions: Despite the increased hemodynamic demands after pediatric KT with large donor-recipient size mismatch, improved LV function and reduced left ventricular mass were found within 1 year after transplantation. These results suggest reversed cardiac remodeling.
- Open Access
- 12 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0339353
“On paper it was a surgical success, but the reality was very different”: A qualitative interview study using narrated casuistry to explore patient context in specialist care
Objective: Approaches such as shared decision-making emphasize effective patient-provider communication to ensure that patient preferences are integrated into clinical practice. However, they often overlook crucial aspects of patient context, which can affect the appropriateness and feasibility of care planning. Applying a contextual care model addresses this gap, yet the extent to which relevant patient context is considered in routine clinical practice remains largely unknown. Previous studies have primarily focused on the United States, leaving a gap in understanding how care is contextualized in Europe. This study explored how medical specialists in the Netherlands interpret, perceive and incorporate patient context into care planning. Methods: A qualitative interview study was performed with 18 medical specialists from 11 specialties working in academic and peripheral hospitals. Open coding was applied to explore how specialists defined and perceived patient context. Directed content analysis, based on the 4C coding process, was applied to analyze narrated case examples of contextualized and non-contextualized care. Results: All participants acknowledged the importance of patient context for providing appropriate care, though they differed in how broadly they defined it – from physical and cognitive abilities, to social, emotional and environmental circumstances. Context was considered most relevant for making treatment decisions and, by half of the participants, for ongoing monitoring of treatment. Participants also described cases where contextualization developed over time or was shared among team members. Key challenges included distinguishing context from patient preferences and sufficiently probing red flags to inform care planning. Conclusion: Medical specialists emphasized the essential role of patient context in enabling personalized and efficient decision-making, enhancing care monitoring, and ultimately improving clinical outcomes. However, systematic and continuous integration of contextual information into decision-making remains challenging. Addressing this requires proactive exploration, improved communication training, and organizational support to embed contextualized care in routine practice.
- 12 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0339353
Open Access“On paper it was a surgical success, but the reality was very different”: A qualitative interview study using narrated casuistry to explore patient context in specialist care
Objective: Approaches such as shared decision-making emphasize effective patient-provider communication to ensure that patient preferences are integrated into clinical practice. However, they often overlook crucial aspects of patient context, which can affect the appropriateness and feasibility of care planning. Applying a contextual care model addresses this gap, yet the extent to which relevant patient context is considered in routine clinical practice remains largely unknown. Previous studies have primarily focused on the United States, leaving a gap in understanding how care is contextualized in Europe. This study explored how medical specialists in the Netherlands interpret, perceive and incorporate patient context into care planning. Methods: A qualitative interview study was performed with 18 medical specialists from 11 specialties working in academic and peripheral hospitals. Open coding was applied to explore how specialists defined and perceived patient context. Directed content analysis, based on the 4C coding process, was applied to analyze narrated case examples of contextualized and non-contextualized care. Results: All participants acknowledged the importance of patient context for providing appropriate care, though they differed in how broadly they defined it – from physical and cognitive abilities, to social, emotional and environmental circumstances. Context was considered most relevant for making treatment decisions and, by half of the participants, for ongoing monitoring of treatment. Participants also described cases where contextualization developed over time or was shared among team members. Key challenges included distinguishing context from patient preferences and sufficiently probing red flags to inform care planning. Conclusion: Medical specialists emphasized the essential role of patient context in enabling personalized and efficient decision-making, enhancing care monitoring, and ultimately improving clinical outcomes. However, systematic and continuous integration of contextual information into decision-making remains challenging. Addressing this requires proactive exploration, improved communication training, and organizational support to embed contextualized care in routine practice.
- 14 August 2024
- Published by SAGE Publications in Progress in Transplantation
- Vol. 34 (3) , 89-95
A Mixed Method Study in Young Children Participating in Clinical Research During A Kidney Transplantation Trajectory
Introduction: Regulations designed to protect children participating in clinical research often restrict the availability of research data necessary for the development of age-specific therapies and drug dosing. Few data exist on how children experience participation in clinical research, and studies investigating young children undergoing an intensive medical treatment are lacking. Methods: Mixed methods with semi-structured interviews and DISCO-RC questionnaires were used to explore young children's and their parents’ experiences in clinical research participation during a kidney transplantation trajectory. Findings: Nine children and their parents were interviewed. Children's median age at kidney transplantation was 4 years (IQR 4,7); age at interview was 7 years (IQR 6,9). Thematic content analysis of interviews revealed that most children were unaware of having participated in a study. Both children and their parents frequently were unaware whether procedures were standard care or research related. The additional burden attributed to study participation varied from not at all to heavy in combination with intensive medical treatment. Positive experiences included kind healthcare professionals, effective distraction techniques, educational aspects, contributing to science and extra check-ups. Most reported negative experiences were conflicting communication, spending much time in the hospital, missing school and suboptimal planning. Venous puncture was stressful for all children, whereas the discomfort of other procedures varied. Conclusion: Pediatric clinical research design should focus on education and fun during research procedures, smart planning, consistent communication, close collaboration between clinical and research team and age appropriate distraction techniques.
- 14 August 2024
- Published by SAGE Publications in Progress in Transplantation
- Vol. 34 (3) , 89-95
A Mixed Method Study in Young Children Participating in Clinical Research During A Kidney Transplantation Trajectory
Introduction: Regulations designed to protect children participating in clinical research often restrict the availability of research data necessary for the development of age-specific therapies and drug dosing. Few data exist on how children experience participation in clinical research, and studies investigating young children undergoing an intensive medical treatment are lacking. Methods: Mixed methods with semi-structured interviews and DISCO-RC questionnaires were used to explore young children's and their parents’ experiences in clinical research participation during a kidney transplantation trajectory. Findings: Nine children and their parents were interviewed. Children's median age at kidney transplantation was 4 years (IQR 4,7); age at interview was 7 years (IQR 6,9). Thematic content analysis of interviews revealed that most children were unaware of having participated in a study. Both children and their parents frequently were unaware whether procedures were standard care or research related. The additional burden attributed to study participation varied from not at all to heavy in combination with intensive medical treatment. Positive experiences included kind healthcare professionals, effective distraction techniques, educational aspects, contributing to science and extra check-ups. Most reported negative experiences were conflicting communication, spending much time in the hospital, missing school and suboptimal planning. Venous puncture was stressful for all children, whereas the discomfort of other procedures varied. Conclusion: Pediatric clinical research design should focus on education and fun during research procedures, smart planning, consistent communication, close collaboration between clinical and research team and age appropriate distraction techniques.
- Open Access
- 8 December 2023
- Published by Wiley in Pediatric Anesthesia
- Vol. 34 (3) , 235-242
Anesthesia and intensive care unit care in pediatric kidney transplantation: An international survey
Background: Despite the high perioperative risk profile, international guidelines for anesthesia and intensive care unit (ICU) care in pediatric kidney transplantation do not exist. Optimizing hemodynamics can be challenging in these patients, while scientific data to guide decisions in hemodynamic monitoring, hemodynamic targets, and perioperative fluid management are lacking. The limited annual number of pediatric kidney transplantations, even in reference centers, necessitates the urge for international collaboration to share knowledge and develop research and guidelines. The aim of this study was to collect data on current perioperative anesthesia and ICU care practices in pediatric kidney transplantation.Methods: An international survey with an anonymized link was sent from a validated electronic data capture system (Castor). Inclusion criteria were: medical doctor in anesthesia, (ICU), or pediatric nephrology working in a pediatric kidney transplantation specialized center; and signed informed consent. Data were analyzed using descriptive statistics.Results: Thirty-three records were analyzed. Responders were anesthesiologists (58%), pediatric nephrologists (30%), and pediatric intensivists (12%), representing 13 countries worldwide. About half of the centers (48%) performed more than 10 pediatric kidney transplantations a year. Perioperative hemodynamic support was guided by intra-arterial blood pressure (88%), central venous pressure (CVP; 88%), and cardiac output (CO; 39%). The most variation was seen in the hemodynamic targets CVP and CO, fluid administration, and inotrope/vasopressor use. The protocolized use of furosemide (46%) and mannitol (61%) also varied between centers. Postoperative care for the youngest recipients occurred in the pediatric intensive care unit at all centers.Conclusion: The results of this survey reveal a large variation in anesthesia and ICU care in pediatric kidney transplantation centers worldwide, particularly in CVP and CO targets, hemodynamic therapy, and the use of furosemide and mannitol. These data identify areas for further research and can be a starting point for international research collaboration and guideline development.
- 8 December 2023
- Published by Wiley in Pediatric Anesthesia
- Vol. 34 (3) , 235-242
Open AccessAnesthesia and intensive care unit care in pediatric kidney transplantation: An international survey
Background: Despite the high perioperative risk profile, international guidelines for anesthesia and intensive care unit (ICU) care in pediatric kidney transplantation do not exist. Optimizing hemodynamics can be challenging in these patients, while scientific data to guide decisions in hemodynamic monitoring, hemodynamic targets, and perioperative fluid management are lacking. The limited annual number of pediatric kidney transplantations, even in reference centers, necessitates the urge for international collaboration to share knowledge and develop research and guidelines. The aim of this study was to collect data on current perioperative anesthesia and ICU care practices in pediatric kidney transplantation.Methods: An international survey with an anonymized link was sent from a validated electronic data capture system (Castor). Inclusion criteria were: medical doctor in anesthesia, (ICU), or pediatric nephrology working in a pediatric kidney transplantation specialized center; and signed informed consent. Data were analyzed using descriptive statistics.Results: Thirty-three records were analyzed. Responders were anesthesiologists (58%), pediatric nephrologists (30%), and pediatric intensivists (12%), representing 13 countries worldwide. About half of the centers (48%) performed more than 10 pediatric kidney transplantations a year. Perioperative hemodynamic support was guided by intra-arterial blood pressure (88%), central venous pressure (CVP; 88%), and cardiac output (CO; 39%). The most variation was seen in the hemodynamic targets CVP and CO, fluid administration, and inotrope/vasopressor use. The protocolized use of furosemide (46%) and mannitol (61%) also varied between centers. Postoperative care for the youngest recipients occurred in the pediatric intensive care unit at all centers.Conclusion: The results of this survey reveal a large variation in anesthesia and ICU care in pediatric kidney transplantation centers worldwide, particularly in CVP and CO targets, hemodynamic therapy, and the use of furosemide and mannitol. These data identify areas for further research and can be a starting point for international research collaboration and guideline development.
- Open Access
- 20 November 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (1) , e14637
Hemodynamics and urinary excretion of kidney‐injury biomarkers in pediatric kidney transplantation
- 20 November 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (1) , e14637
Open AccessHemodynamics and urinary excretion of kidney‐injury biomarkers in pediatric kidney transplantation
- Open Access
- 11 August 2021
- Published by Wiley in Pediatric Anesthesia
- Vol. 31 (11) , 1150-1160
Perioperative anesthesia care for the pediatric patient undergoing a kidney transplantation: An educational review
Living‐donor kidney transplantation is the first choice therapy for children with end‐stage renal disease and shows good long‐term outcome. Etiology of renal failure, co‐morbidities, and hemodynamic effects, due to donor‐recipient size mismatch, differs significantly from those in adult patients. Despite the complexities related to both patient and surgery, there is a lack of evidence‐based anesthesia guidelines for pediatric kidney transplantation. This educational review summarizes the pathophysiological changes to consider and suggests recommendations for perioperative anesthesia care, based on recent research papers.
- 11 August 2021
- Published by Wiley in Pediatric Anesthesia
- Vol. 31 (11) , 1150-1160
Open AccessPerioperative anesthesia care for the pediatric patient undergoing a kidney transplantation: An educational review
Living‐donor kidney transplantation is the first choice therapy for children with end‐stage renal disease and shows good long‐term outcome. Etiology of renal failure, co‐morbidities, and hemodynamic effects, due to donor‐recipient size mismatch, differs significantly from those in adult patients. Despite the complexities related to both patient and surgery, there is a lack of evidence‐based anesthesia guidelines for pediatric kidney transplantation. This educational review summarizes the pathophysiological changes to consider and suggests recommendations for perioperative anesthesia care, based on recent research papers.
- Open Access
- 5 January 2021
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 36 (1) , 141-145
Safety aspects of the PiCCO thermodilution-cardiac output catheter during magnetic resonance imaging at 3 Tesla
Thermodilution cardiac output monitoring, using a thermistor-tipped intravascular catheter, is used in critically ill patients to guide hemodynamic therapy. Often, these patients also need magnetic resonance imaging (MRI) for diagnostic or prognostic reasons. As thermodilution catheters contain metal, they are considered MRI-unsafe and advised to be removed prior to investigation. However, removal and replacement of the catheter carries risks of bleeding, perforation and infection. This research is an in vitro safety assessment of the PiCCO™ thermodilution catheter during 3 T Magnetic Resonance Imaging (3T-MRI). In a 3T-MRI environment, three different PiCCO™ catheter sizes were investigated in an agarose-gel, tissue mimicking phantom. Two temperature probes measured radiofrequency-induced heating; one at the catheter tip and one at a reference point. Magnetically induced catheter dislocation was assessed by visual observation as well as by analysis of the tomographic images. For all tested catheters, the highest measured temperature increase was 0.2 °C at the center of the bore and 0.3 °C under “worst-case” setting for the tested MRI pulse sequences. No magnetically induced catheter displacements were observed. Under the tested circumstances, no heating or dislocation of the PiCCO™ catheter was observed in a tissue mimicking phantom during 3T-MRI. Leaving the catheter in the critically ill patient during MRI investigation might pose a lower risk of complications than catheter removal and replacement.
- 5 January 2021
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 36 (1) , 141-145
Open AccessSafety aspects of the PiCCO thermodilution-cardiac output catheter during magnetic resonance imaging at 3 Tesla
Thermodilution cardiac output monitoring, using a thermistor-tipped intravascular catheter, is used in critically ill patients to guide hemodynamic therapy. Often, these patients also need magnetic resonance imaging (MRI) for diagnostic or prognostic reasons. As thermodilution catheters contain metal, they are considered MRI-unsafe and advised to be removed prior to investigation. However, removal and replacement of the catheter carries risks of bleeding, perforation and infection. This research is an in vitro safety assessment of the PiCCO™ thermodilution catheter during 3 T Magnetic Resonance Imaging (3T-MRI). In a 3T-MRI environment, three different PiCCO™ catheter sizes were investigated in an agarose-gel, tissue mimicking phantom. Two temperature probes measured radiofrequency-induced heating; one at the catheter tip and one at a reference point. Magnetically induced catheter dislocation was assessed by visual observation as well as by analysis of the tomographic images. For all tested catheters, the highest measured temperature increase was 0.2 °C at the center of the bore and 0.3 °C under “worst-case” setting for the tested MRI pulse sequences. No magnetically induced catheter displacements were observed. Under the tested circumstances, no heating or dislocation of the PiCCO™ catheter was observed in a tissue mimicking phantom during 3T-MRI. Leaving the catheter in the critically ill patient during MRI investigation might pose a lower risk of complications than catheter removal and replacement.
- Open Access
- 15 July 2019
- Published by Wiley in Pediatric Anesthesia
- Vol. 29 (9) , 950-958
Cardiac output‐guided hemodynamic therapy for adult living donor kidney transplantation in children under 20 kg: A pilot study
Background: A living‐donor (adult) kidney transplantation in young children requires an increased cardiac output to maintain adequate perfusion of the relatively large kidney. To achieve this, protocols commonly advise liberal fluid administration guided by high target central venous pressure. Such therapy may lead to good renal outcomes, but the risk of tissue edema is substantial.Aims: We aimed to evaluate the safety and feasibility of the transpulmonary thermodilution technique to measure cardiac output in pediatric recipients. The second aim was to evaluate whether a cardiac output‐guided hemodynamic therapy algorithm could induce less liberal fluid administration, while preserving good renal results and achieving increased target cardiac output and blood pressure.Methods: In twelve consecutive recipients, cardiac output was measured with transpulmonary thermodilution (PiCCO device, Pulsion). The algorithm steered administration of fluids, norepinephrine and dobutamine. Hemodynamic values were obtained before, during and after transplantation. Results are given as mean (SD) [minimum‐maximum].Results: Age and weight of recipients was 3.2 (0.97) [1.6‐4.9] yr and 14.1 (2.4) [10.4‐18] kg, respectively. No complications related to cardiac output monitoring occurred. After transplantation, cardiac index increased with 31% (95% CI = 15%‐48%). Extravascular lung water and central venous pressure did not change. Fluids given decreased from 158 [124‐191] mL kg−1 in the first 2 patients to 80 (18) [44‐106] mL kg−1 in the last 10 patients. The latter amount was 23 mL kg−1 less (95% CI = 6‐40 mL kg−1) than in one recent study, but similar to that in another. After reperfusion, all patients received norepinephrine (maximum dose 0.45 (0.3) [0.1‐0.9] mcg kg−1 min−1). Patient and graft survivals were 100% with excellent kidney function at 6 months post‐transplantation.Conclusion: Transpulmonary thermodilution‐cardiac output monitoring appeared to be safe and feasible. Using the cardiac output‐guided algorithm led to excellent renal results with a trend toward less fluids in favor of norepinephrine.
- 15 July 2019
- Published by Wiley in Pediatric Anesthesia
- Vol. 29 (9) , 950-958
Open AccessCardiac output‐guided hemodynamic therapy for adult living donor kidney transplantation in children under 20 kg: A pilot study
Background: A living‐donor (adult) kidney transplantation in young children requires an increased cardiac output to maintain adequate perfusion of the relatively large kidney. To achieve this, protocols commonly advise liberal fluid administration guided by high target central venous pressure. Such therapy may lead to good renal outcomes, but the risk of tissue edema is substantial.Aims: We aimed to evaluate the safety and feasibility of the transpulmonary thermodilution technique to measure cardiac output in pediatric recipients. The second aim was to evaluate whether a cardiac output‐guided hemodynamic therapy algorithm could induce less liberal fluid administration, while preserving good renal results and achieving increased target cardiac output and blood pressure.Methods: In twelve consecutive recipients, cardiac output was measured with transpulmonary thermodilution (PiCCO device, Pulsion). The algorithm steered administration of fluids, norepinephrine and dobutamine. Hemodynamic values were obtained before, during and after transplantation. Results are given as mean (SD) [minimum‐maximum].Results: Age and weight of recipients was 3.2 (0.97) [1.6‐4.9] yr and 14.1 (2.4) [10.4‐18] kg, respectively. No complications related to cardiac output monitoring occurred. After transplantation, cardiac index increased with 31% (95% CI = 15%‐48%). Extravascular lung water and central venous pressure did not change. Fluids given decreased from 158 [124‐191] mL kg−1 in the first 2 patients to 80 (18) [44‐106] mL kg−1 in the last 10 patients. The latter amount was 23 mL kg−1 less (95% CI = 6‐40 mL kg−1) than in one recent study, but similar to that in another. After reperfusion, all patients received norepinephrine (maximum dose 0.45 (0.3) [0.1‐0.9] mcg kg−1 min−1). Patient and graft survivals were 100% with excellent kidney function at 6 months post‐transplantation.Conclusion: Transpulmonary thermodilution‐cardiac output monitoring appeared to be safe and feasible. Using the cardiac output‐guided algorithm led to excellent renal results with a trend toward less fluids in favor of norepinephrine.